Abbott gets FDA nod for software to help doctors open blocked arteries
May 3, 2026: The US Food and Drug Administration has cleared Abbott Laboratories’ new artificial-intelligence-powered software for coronary imaging, enabling doctors to have.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
May 3, 2026: The US Food and Drug Administration has cleared Abbott Laboratories’ new artificial-intelligence-powered software for coronary imaging, enabling doctors to have.
Swiss healthcare multinational F. Hoffmann-La Roche AG will acquire US-based 89bio Inc. for a deal worth up to $3.5 billion to expand its.
Swedish-British AstraZeneca Plc’s medicine baxdrostat lowered blood pressure in trial patients during an end-stage study, and the company plans to file for regulatory.
Novo Nordisk A/S, a Danish pharmaceutical company, has expanded its agreement with US-based Valo Health Inc., almost to double the number of drugs.
Fifty-three nations have adopted best practice policies to eliminate trans fats in foods — benefitting 46% of the world’s population, or about 3.7.
HQ Team October 16, 2023: Danish pharmaceutical company, Novo Nordisk, announced it was buying a hypertension drug, still in trials, from Singapore-based KBP.
HQ Team July 26, 2023: Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to.
HQ Team May 15, 2023: The use of non-sugar sweeteners leads to an increased risk of type 2 diabetes, cardiovascular diseases, and mortality.
HQ Team April 14, 2023: SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk.
China, the US, and India are expected to have the highest economic cost of overweight and obesity, a study by the World Obesity.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)